ARCHIVES

Xeloda-Eloxatin Study Updated; Phase III Trial Interim Analysis

This article is from The Cancer Letter archive.

Vol. 25 No. 12 | December 27, 2002

Download PDF Visit The Full Archive

Related Articles

New Predictive Score May Help In Planning Adjuvant Therapy

September 26, 2008

DCCP Board Defers Two Concept Requests, Approves Sole Sources

October 22, 1982

In Brief: Terry To Leave NCI for Job As VP Of Revlon Health Care Group; NCI Tracking Source Of Breakthroughs

June 18, 1982

Breast Cancer Risk Rises To 1 Woman In 9

February 1, 1991

Reviewers Find I-ELCAP Is A Trial That Never Ends, With 90 Percent of Consent Forms Unobtainable

April 29, 2011

Cancer Panel To Examine Health Of Phase I Trials

May 17, 1996